Literature DB >> 2884340

Antimuscarinic effects of antihistamines: quantitative evaluation by receptor-binding assay.

N Kubo, O Shirakawa, T Kuno, C Tanaka.   

Abstract

Quantitative evaluation of antimuscarinic effects of antihistamines (H1- and H2-receptor antagonists) was carried out using a receptor-binding assay. The -inhibition constants (Ki values) of twenty seven H1-receptor antagonists, one related antidepressant and three H2-receptor antagonists at H1-receptors and muscarinic receptors in the bovine cerebral cortex were determined. All the H2-receptor antagonists examined showed very low affinity for the muscarinic receptors. On the other hand, some H1-receptor antagonists (mequitazine, cyproheptazine, clemastine, diphenylpyraline, promethazine, homochlorcyclizine and alimemazine) had high affinity for the muscarinic receptors (Ki = 5.0-38 nM). Another group of H1-receptor antagonists (mepyramine, terfenadine, metapyrilen, azelastine, hydroxyzine and meclizine) had low affinity for the muscarinic receptors (Ki = 3,600-30,000 nM). Thus, a broad range of antimuscarinic potencies among the antihistamines was demonstrated. These results should provide helpful information with regard to the clinical and experimental use of antihistamines.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2884340     DOI: 10.1254/jjp.43.277

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  31 in total

1.  Identifying mechanism-of-action targets for drugs and probes.

Authors:  Elisabet Gregori-Puigjané; Vincent Setola; Jérôme Hert; Brenda A Crews; John J Irwin; Eugen Lounkine; Lawrence Marnett; Bryan L Roth; Brian K Shoichet
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-18       Impact factor: 11.205

2.  High-content pSTAT3/1 imaging assays to screen for selective inhibitors of STAT3 pathway activation in head and neck cancer cell lines.

Authors:  Paul A Johnston; Malabika Sen; Yun Hua; Daniel Camarco; Tong Ying Shun; John S Lazo; Jennifer R Grandis
Journal:  Assay Drug Dev Technol       Date:  2013-10-15       Impact factor: 1.738

3.  Case files of the medical toxicology fellowship at Drexel University. Rhabdomyolysis and compartment syndrome following acute diphenhydramine overdose.

Authors:  David Vearrier; John A Curtis
Journal:  J Med Toxicol       Date:  2011-09

4.  Antiperspirant activity of H1-histamine blockers as determined by a modified rat foot pad assay.

Authors:  M D Helman; T A Re; A B Lukacsko
Journal:  Pharm Res       Date:  1989-10       Impact factor: 4.200

5.  Cisplatin Toxicity in Dorsal Root Ganglion Neurons Is Relieved by Meclizine via Diminution of Mitochondrial Compromise and Improved Clearance of DNA Damage.

Authors:  Murat F Gorgun; Ming Zhuo; Ella W Englander
Journal:  Mol Neurobiol       Date:  2016-11-17       Impact factor: 5.590

Review 6.  The Importance of Medicinal Chemistry Knowledge in the Clinical Pharmacist's Education.

Authors:  João Paulo S Fernandes
Journal:  Am J Pharm Educ       Date:  2018-03       Impact factor: 2.047

7.  Sedation and histamine H1-receptor antagonism: studies in man with the enantiomers of chlorpheniramine and dimethindene.

Authors:  A N Nicholson; P A Pascoe; C Turner; C R Ganellin; P M Greengrass; A F Casy; A D Mercer
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

Review 8.  Drug-induced hyperhidrosis and hypohidrosis: incidence, prevention and management.

Authors:  William P Cheshire; Robert D Fealey
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

9.  Identification of an Ascaris G protein-coupled acetylcholine receptor with atypical muscarinic pharmacology.

Authors:  Michael J Kimber; Laura Sayegh; Fouad El-Shehabi; Chuanzhe Song; Mostafa Zamanian; Debra J Woods; Tim A Day; Paula Ribeiro
Journal:  Int J Parasitol       Date:  2009-03-25       Impact factor: 3.981

10.  Chlorpheniramine exerts anxiolytic-like effects and activates prefrontal 5-HT systems in mice.

Authors:  Shigeo Miyata; Shoko Hirano; Masahiro Ohsawa; Junzo Kamei
Journal:  Psychopharmacology (Berl)       Date:  2009-10-13       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.